News
4317 posts · page 37 of 180
SimonMed Unveils New Preventive Heart Screening Initiative
SimonMed Imaging introduces a preventive heart screening program to enhance early detection and treatment of cardiovascular conditions.
CVS Health Celebrates 20 Years of Free Community Health Screenings
CVS Health marks two decades of providing free health screenings, benefiting communities nationwide.
Concierge Medicine Shakes Up Traditional Healthcare Models
Concierge medicine is redefining patient care by offering personalized services, challenging established healthcare practices.
Concierge Medicine: Navigating Benefits and Ethical Challenges
Concierge medicine offers personalized care but raises ethical concerns about healthcare access.
Medtronic Raises Fiscal 2027 Forecasts Amid Heart Device Demand Surge
Medtronic boosts fiscal 2027 outlook due to strong heart device demand and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics posted a Rs 52.74 crore profit in Q1, reversing last year's loss, driven by Truenat test-kit sales.
Medtronic Raises 2027 Forecasts on Heart Device Sales Surge
Medtronic boosts its fiscal 2027 outlook amid rising demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 Post-IPO
Molbio Diagnostics achieved a Rs 52.7 crore profit in Q1, reversing last year's loss with strong demand for Truenat test-kits.
Medtronic Raises Fiscal 2027 Forecasts Amid Heart Device Surge
Medtronic boosts fiscal 2027 outlook, driven by robust demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Following IPO
Molbio Diagnostics, newly listed on the stock market, reported a Q1 profit of Rs 52.7 crore, reversing last year's losses.
Major Initiative Launched to Halve U.S. Maternal Death Rate
A $100 million pledge aims to reduce the U.S. maternal mortality rate by 50%, tackling preventable deaths.
Medtronic Raises 2027 Forecasts Amid Heart Device Surge
Medtronic boosts fiscal 2027 outlook, driven by heart device demand and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics, newly listed on stock exchanges, posts Rs 52.7 crore profit in Q1, rebounding from Rs 23.94 crore loss last year.
Medtronic Raises 2027 Forecasts Amid Heart Device Surge
Medtronic increases 2027 revenue forecasts, driven by strong demand for cardiovascular devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 Post-IPO
Molbio Diagnostics achieved a Rs 52.7 crore profit in Q1, reversing a loss from last year, driven by high demand for its Truenat test kits.
Nigerian Government Targets Gender Norms for Adolescent Health Gains
Nigeria's government urges action against harmful gender norms to enhance adolescent health outcomes.
Supreme Court Dismisses Plea Against India's HPV Vaccine Initiative
The Supreme Court has declined to consider a petition challenging the HPV vaccination program, affirming its continuation.
Genetic Profiling Advances Cystic Fibrosis Prenatal Diagnosis
New genetic profiling techniques improve early detection of cystic fibrosis, offering better outcomes for families.
Advancements in Prenatal Diagnosis of Anoxic Cerebral Lesions
New techniques in prenatal imaging enhance early detection of anoxic cerebral lesions, potentially improving outcomes.
Case Report: Fetal Ascites Challenges in Twin Pregnancy
A rare case of massive fetal ascites in a twin pregnancy highlights complex prenatal challenges.
Medtronic Raises Fiscal 2027 Outlook Amid Heart Device Surge
Medtronic boosts its fiscal 2027 forecasts, driven by strong demand for heart devices and strategic investments.
Molbio Diagnostics Records Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics reports Rs 52.7 crore profit in Q1, a turnaround from last year's loss, driven by strong sales of Truenat test-kits.
Medtronic Raises 2027 Projections Amid Surge in Heart Device Demand
Medtronic lifts its 2027 revenue forecasts, driven by robust heart device demand and strategic investments.
Molbio Diagnostics Sees Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics reports a Rs 52.7 crore profit in Q1 after its IPO, reversing a Rs 23.94 crore loss from last year.